Alpha-adducin (ADD1) methylation as a potential epigenetic biomarker for young adults with prehypertension.

Wan Omar, Wan Fatein Nabeila and A.Talib, Norlelawati and Abdullah, Aszrin and Ab Rahman, Jamalludin and Mohd Shah, Azarisman Shah (2019) Alpha-adducin (ADD1) methylation as a potential epigenetic biomarker for young adults with prehypertension. In: Hypertension Seoul 2019 in conjunction with the 51st Scientific Meeting of the Korean Society of Hypertension, 8th November 2019 - 9th November 2019, Conrad Hotel, Seoul, Republic of Korea. (Unpublished)

	PDF (poster) - Published Version Restricted to Repository staff only Download (579kB) | Request a copy
	PDF (Program book) - Supplemental Material Restricted to Registered users only Download (550kB) | Request a copy

Abstract

Introduction: Prehypertension is a pre-disease state of hypertension, with a conversion rate of up to 37% in 5 years. Epigenetic changes have been proposed to play a role in the etiopathogenesis. The epigenetic changes in -Adducin (ADD1) gene in prehypertensive state in young adults is yet to be explored. The aim of this study was to investigate the association between ADD1 gene promoter methylation and blood pressure in young adults. Methods: An observational cross-sectional study was conducted involving subjects age 18 to 45 years in Kuantan, Pahang, Malaysia who fulfils prehypertension and normotension blood pressure range using The Seventh Report of the Joint National Committee (JNC7) definition. MethyLight analysis was used to determine DNA methylation levels of ADD1 gene promoter in blood DNA samples from 80 subjects with prehypertension and 80 normotensive control subjects. Results: The mean level of ADD1 methylation was 1.2480.022. Prehypertensives had significantly lower ADD1 methylation than normotensive controls [1.2410.020 vs. 1.256 0.020; p<0.001]. Sex-specific analysis showed that both males and females exhibited similar trend. After adjusting for other covariates, ADD1 methylation predicted prehypertension in males (p=0.003) and approaching significance for females (p=0.050). Conclusion: The level of ADD1 methylation in the DNA of subjects with prehypertension is lower than normotensive controls. ADD1 methylation is an independent predictor of prehypertension in males, hence could serve as a potential biomarker.

Item Type:	Conference or Workshop Item (Poster)
Additional Information:	7963/83535
Uncontrolled Keywords:	Epigenetics, MethyLight, salt-sensitive gene, DNA methylation
Subjects:	Q Science > QH Natural history > QH426 Genetics Q Science > QP Physiology R Medicine > RC Internal medicine > RC627 Specialties of Internal Medicine-Metabolic Diseases R Medicine > RC Internal medicine > RC667 Specialties of Internal Medicine-Diseases of Circulatory (Cardiovascular) System
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Medicine > Department of Basic Medical Kulliyyah of Medicine > Department of Community Medicine (Effective: 1st January 2011) Kulliyyah of Medicine > Department of Internal Medicine Kulliyyah of Medicine > Department of Pathology & Lab Medicine Kulliyyah of Medicine
Depositing User:	Dr Wan Fatein Nabeila Wan Omar
Date Deposited:	09 Oct 2020 16:46
Last Modified:	09 Oct 2020 16:46
URI:	http://irep.iium.edu.my/id/eprint/83535

Actions (login required)

View Item